BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: La Rosa S, Franzi F, Albarello L, Schmitt A, Bernasconi B, Tibiletti MG, Finzi G, Placidi C, Perren A, Capella C. Serotonin-Producing Enterochromaffin Cell Tumors of the Pancreas: Clinicopathologic Study of 15 Cases and Comparison With Intestinal Enterochromaffin Cell Tumors. Pancreas 2011;40:883-95. [DOI: 10.1097/mpa.0b013e31822041a9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Milanetto AC, Fassan M, David A, Pasquali C. Serotonin-Secreting Neuroendocrine Tumours of the Pancreas. J Clin Med 2020;9:E1363. [PMID: 32384679 DOI: 10.3390/jcm9051363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lam AK, Ishida H. Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging. Histol Histopathol 2021;36:367-82. [PMID: 33305819 DOI: 10.14670/HH-18-288] [Reference Citation Analysis]
3 Zavras N, Schizas D, Machairas N, Damaskou V, Economopoulos N, Machairas A. Carcinoid syndrome from a carcinoid tumor of the pancreas without liver metastases: A case report and literature review. Oncol Lett 2017;13:2373-6. [PMID: 28454406 DOI: 10.3892/ol.2017.5678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 McCall CM, Shi C, Klein AP, Konukiewitz B, Edil BH, Ellison TA, Wolfgang CL, Schulick RD, Klöppel G, Hruban RH. Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Hum Pathol. 2012;43:1169-1176. [PMID: 22221702 DOI: 10.1016/j.humpath.2011.09.014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
5 Ito T, Lee L, Jensen RT. Carcinoid-syndrome: recent advances, current status and controversies. Curr Opin Endocrinol Diabetes Obes 2018;25:22-35. [PMID: 29120923 DOI: 10.1097/MED.0000000000000376] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 12.3] [Reference Citation Analysis]
6 Tsoukalas N, Chatzellis E, Rontogianni D, Alexandraki KI, Boutzios G, Angelousi A, Kaltsas G. Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literature. Medicine (Baltimore) 2017;96:e6201. [PMID: 28422824 DOI: 10.1097/MD.0000000000006201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Kasumova GG, Tabatabaie O, Eskander MF, Tadikonda A, Ng SC, Tseng JF. National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors. J Am Coll Surg 2017;224:1057-64. [PMID: 27965134 DOI: 10.1016/j.jamcollsurg.2016.11.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Depoilly T, Leroux R, Andrade D, Nicolle R, Dioguardi Burgio M, Marinoni I, Dokmak S, Ruszniewski P, Hentic O, Paradis V, De Mestier L, Perren A, Couvelard A, Cros J. Immunophenotypic and molecular characterization of pancreatic neuroendocrine tumors producing serotonin. Mod Pathol 2022. [PMID: 35739266 DOI: 10.1038/s41379-022-01110-x] [Reference Citation Analysis]
9 Guilmette JM, Nosé V. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances. Adv Anat Pathol 2019;26:13-30. [PMID: 29912000 DOI: 10.1097/PAP.0000000000000201] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 13.7] [Reference Citation Analysis]
10 Kasajima A, Konukiewitz B, Schlitter AM, Weichert W, Klöppel G. An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features. Virchows Arch 2021. [PMID: 34499237 DOI: 10.1007/s00428-021-03202-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kidd M, Modlin IM, Drozdov I. Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors. BMC Genomics 2014;15:595. [PMID: 25023465 DOI: 10.1186/1471-2164-15-595] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
12 Herrera-Martínez AD, Feelders RA, Van den Dungen R, Dogan-Oruc F, van Koetsveld PM, Castaño JP, de Herder WW, Hofland LJ. Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells. Neuroendocrinology 2020;110:351-63. [PMID: 31319410 DOI: 10.1159/000502200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA Jr, Vinik AI; CLARINET Study Investigators. Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors. Oncologist 2019;24:463-74. [PMID: 30355775 DOI: 10.1634/theoncologist.2018-0217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]